98 related articles for article (PubMed ID: 10537368)
21. Plasma levels of vascular endothelial growth factor (VEGF) in haematological cancers.
Belgore FM; Lip GY; Bareford D; Blann AD
Br J Haematol; 2000 Aug; 110(2):496-7. PubMed ID: 11023294
[No Abstract] [Full Text] [Related]
22. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer.
Oehler MK; Caffier H
Anticancer Res; 2000; 20(6D):5109-12. PubMed ID: 11326678
[TBL] [Abstract][Full Text] [Related]
23. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
Peng XP; Li JD; Li MD; Ye XM; Yan WC
Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor serum levels in pregnancy and preeclampsia.
Hefler L; Obermair A; Husslein P; Kainz C; Tempfer C
Acta Obstet Gynecol Scand; 2000 Jan; 79(1):77-8. PubMed ID: 10646821
[No Abstract] [Full Text] [Related]
25. The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer.
Werther K; Christensen IJ; Nielsen HJ;
Eur J Surg; 2001 Apr; 167(4):287-92. PubMed ID: 11354321
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor: promise or peril?
Kipshidze N
Am J Cardiol; 1999 Jun; 83(11):1592. PubMed ID: 10363882
[No Abstract] [Full Text] [Related]
27. Elevated plasma concentration of vascular endothelial growth factor in cardiac myxoma.
Bennett KR; Gu JW; Adair TH; Heath BJ
J Thorac Cardiovasc Surg; 2001 Jul; 122(1):193-4. PubMed ID: 11436061
[No Abstract] [Full Text] [Related]
28. The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer.
Lantzsch T; Hefler L; Krause U; Kehl A; Goepel C; Koelbl H; Dunst J; Lampe D
Anticancer Res; 2002; 22(3):1925-8. PubMed ID: 12168895
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.
George DJ; Halabi S; Shepard TF; Vogelzang NJ; Hayes DF; Small EJ; Kantoff PW;
Clin Cancer Res; 2001 Jul; 7(7):1932-6. PubMed ID: 11448906
[TBL] [Abstract][Full Text] [Related]
30. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer.
Feldman AL; Tamarkin L; Paciotti GF; Simpson BW; Linehan WM; Yang JC; Fogler WE; Turner EM; Alexander HR; Libutti SK
Clin Cancer Res; 2000 Dec; 6(12):4628-34. PubMed ID: 11156212
[TBL] [Abstract][Full Text] [Related]
31. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver mestastasis vascularity and volume.
Davies MM; Jonas SK; Kaur S; Allen-Mersh TG
Br J Cancer; 2000 Mar; 82(5):1004-8. PubMed ID: 10737380
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of vascular endothelial growth factor in chronic leukemias. A comparative study with emphasis on myeloproliferative disorders.
Molica S; Santoro R; Iuliano F; Di Raimondo F; Fichera E; Giustolisi R
Haematologica; 2001 Jul; 86(7):771. PubMed ID: 11454538
[No Abstract] [Full Text] [Related]
33. Plasma vascular endothelial growth factor levels in scleroderma are not correlated with disease activity.
Viac J; Schmitt D; Claudy A
Acta Derm Venereol; 2000; 80(5):383. PubMed ID: 11200843
[No Abstract] [Full Text] [Related]
34. Circulating vascular endothelial growth factor correlates with systemic thrombin generation in patients with pancreatic carcinoma.
Chinswangwatanakul V; Worthington T; Lemoine NR; Williamson RC; Kakkar AK
Thromb Haemost; 1999 May; 81(5):851. PubMed ID: 10365767
[No Abstract] [Full Text] [Related]
35. Vascular endothelial growth factor in plasma of patients undergoing peripheral angioplasty.
Roller RE; Renner W; Tischler R; Pilger E; Schnedl WJ
Thromb Haemost; 2001 Jun; 85(6):1119-20. PubMed ID: 11434696
[No Abstract] [Full Text] [Related]
36. [Vascular endothelial growth factor and Crow-Fukase syndrome].
Arimura K; Osame M; Hashiguchi T
Rinsho Shinkeigaku; 2001 Dec; 41(12):1144-6. PubMed ID: 12235821
[TBL] [Abstract][Full Text] [Related]
37. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
[TBL] [Abstract][Full Text] [Related]
38. Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status.
Heer K; Kumar H; Read JR; Fox JN; Monson JR; Kerin MJ
Clin Cancer Res; 2001 Nov; 7(11):3491-4. PubMed ID: 11705867
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum vascular endothelial growth factor levels in patients with polycythemia vera and thrombotic complications.
Cacciola RR; Di Francesco E; Giustolisi R; Cacciola E
Haematologica; 2002 Jul; 87(7):774-5. PubMed ID: 12091131
[TBL] [Abstract][Full Text] [Related]
40. Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment.
Wu Y; Saldana L; Chillar R; Vadgama JV
Int J Oncol; 2002 Mar; 20(3):509-16. PubMed ID: 11836562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
